BLX Q1 2026 Earnings Solid EPS Performance Amid Market Volatility ALTO Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher Amid Operational Improvements Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline VERX Q1 2026 Earnings Modest EPS Beat Amid Strong Operational Execution ARM Q1 2026 Earnings EPS Beats Estimates Amid Strong Licensing Demand REYN Q1 2026 Earnings EPS Surpasses Estimates by 136 Revenue Not Disclosed